250275-15-1

Basic information

• Product Name: cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole
• Synonyms: -Boc-hexahydropyrrolo[3,4-c]pyrrole;tert-butyl (3aR,6aS)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrole-5-carboxylate;CIS-2-BOC-HEXAHYDROPYRROLO[3,4-C]PYRROLE;tert-Butyl hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate;(3aR,6aS)-tert-butyl hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate;2-(tert-Butoxycarbonyl)hexahydropyrrolo[3,4-c]pyrrole;3-Boc-3,7-diazabicyclo[3.3.0]octane;tert-Butyl cis-hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate
• CAS NO: 250275-15-1
• Molecular Formula: C₁₁H₂₀N₂O₂
• Molecular Weight: 212.29
• Product Categories: pharmacetical
• Mol File: 250275-15-1.mol

Chemical Properties

• Boiling Point: 295.397 °C at 760 mmHg
• Flash Point: 132.451 °C
• Appearance: /
• Density: 1.076 g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.494
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 10.72±0.20(Predicted)
• CAS DataBase Reference: cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole(CAS DataBase Reference)
• NIST Chemistry Reference: cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole(250275-15-1)
• EPA Substance Registry System: cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole(250275-15-1)

Safety Data

• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 250275-15-1(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole is used as a building block for the synthesis of various biologically active molecules and pharmaceuticals. Its unique structure and reactivity contribute to the development of new compounds with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole is utilized as a key intermediate in the design and synthesis of novel drug candidates. Its presence in the molecular structure can influence the pharmacological properties and biological activity of the resulting compounds.
Used in Drug Development:
cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole plays a crucial role in drug development, as it can be incorporated into the molecular frameworks of potential therapeutic agents. Its stable nature and ease of synthesis make it an appealing choice for chemists working on the discovery and optimization of new drugs.
Used in Chemical Research:
Researchers in the field of chemical research often employ cis-2-Boc-hexahydropyrrolo[3,4-c]pyrrole as a model compound to study various aspects of chemical reactivity, synthesis, and structure-activity relationships. This helps in advancing the understanding of organic chemistry and its applications in drug discovery and other areas.

InChI:InChI=1/C11H20N2O2/c1-11(2,3)15-10(14)13-6-8-4-12-5-9(8)7-13/h8-9,12H,4-7H2,1-3H3

Upstream product

• 370879-56-4 (3aR,6aS)-tert-butyl 5-benzylhexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 172739-04-7 cis-3-benzyl-3,7-diazabicyclo[3.3.0]octane 
• 24424-99-5 di-tert-butyl dicarbonate 
• 370879-53-1 (3aR,6aS)-5-benzyltetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione 

Downstream Products

• 1194688-13-5 (3aR,6aS)-tert-butyl 5-(5-(benzylamino)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194688-41-9 (3aR,6aS)-tert-butyl 5-(5-(2-methylbenzylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1173179-74-2 tert-butyl cis-5-(6-phenylpyridazine-3-yl)-hexahydro-pyrrolo[3,4-c]-pyrrole-2(1H)-carboxylate 
• 1173179-67-3 tert-butyl cis-5-(4-bromophenyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194687-49-4 (3aR,6aS)-tert-butyl 5-(6-(2-methylbenzylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194687-78-9 (3aR,6aS)-tert-butyl 5-(6-(3-isopropoxyphenylcarbamoyl)pyrazin-2-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194689-10-5 (3aR,6aS)-tert-butyl 5-(5-(benzyl(methyl)carbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194688-54-4 (3aR,6aS)-tert-butyl 5-(5-(2-(trifluoromethyl)benzylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194688-58-8 (3aR,6aS)-tert-butyl 5-(5-(2-fluorophenethylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194689-03-6 (3aR,6aS)-tert-butyl 5-(5-(3-iodophenylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194689-00-3 (3aR,6aS)-tert-butyl 5-(5-(3-isopropoxyphenylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194689-22-9 (3aR,6aS)-tert-butyl 5-(5-(4-chlorophenylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194688-82-8 (3aR,6aS)-tert-butyl 5-(5-(m-tolylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 
• 1194688-85-1 (3aR,6aS)-tert-butyl 5-(5-(3,5-dimethylphenylcarbamoyl)pyridin-3-yl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate 

Relevant articles and documents

QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS

Compounds of formula (I) that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS

Compounds that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for

Novel Octahydropyrrolo[3,4- c ]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate

The preclinical characterization of novel octahydropyrrolo[3,4-c]pyrroles that are potent and selective orexin-2 antagonists is described. Optimization of physicochemical and DMPK properties led to the discovery of compounds with tissue distribution and d

Selective Ligands for the Neuronal Nicotinic Receptors and Uses Thereof

The present application describes selective ligands of formula (I) for neuronal nicotinic receptors (NNRs), more specifically for the α4β2 NNR subtype, compositions thereof, and methods of using the same, wherein X, R1, X, R2, R3, L1, m, n, p, and q are defined in the specification.

Octahydropyrrolo[3,4-c]pyrrole: A diamine scaffold for construction of either α4β2 or α7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity

A series of 5-(pyridine-3-yl)octahydropyrrolo[3,4-c]pyrroles have been prepared that exhibit high affinity to α4β2 and/or α7 nicotinic acetylcholine receptors (nAChRs). Simple substitution patterns have been identified that allow construction of ligands that are highly selective for either nAChR subtype. The effects of substitution on subtype selectivity provide some insight into the differences in the ligand binding domains of the α4β2 and R7 receptors, especially in regions removed from the cation binding pocket.

Diazabicyclic central nervous system active agents

Compounds of formula I pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.